Centiva Capital, LP Lexaria Bioscience Corp. Transaction History

Centiva Capital, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$2.47 - $3.47 $2,470 - $3,470	-1,000 Reduced 7.66%	12,059 $32,000
Q4 2022 Feb 14, 2023	SELL	$2.15 - $2.98 $430 - $596	-200 Reduced 1.51%	13,059 $32,000
Q3 2022 Nov 14, 2022	SELL	$0.74 - $3.17 $666 - $2,853	-900 Reduced 6.36%	13,259 $32,000
Q2 2022 Aug 15, 2022	BUY	N/A	14,159 New	14,159 $42,000

889K

Ticker LEXX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,951,000
Market Cap $16.5M
Description
Lexaria Bioscience Corp. operates as a biotechnology company. Its patented drug delivery technology, DehydraTECH, improves the way active pharmaceutical ingredients enter the bloodstream by promoting effective oral delivery. The company's DehydraTECH has demonstrated the ability to increase bio-absorption with cannabinoids and nicotine by 5-10x ...

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

Stay updated on Centiva Capital, LP with notifications on news.